User profiles for Sobha Sivaprasad

Sobha Sivaprasad

Professor of Retinal Clinical Research
Verified email at nhs.net
Cited by 20256

Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with …

…, EL Lamoureux, IY Wong, NM Bressler, S Sivaprasad… - Jama, 2017 - jamanetwork.com
Importance A deep learning system (DLS) is a machine learning technology with potential
for screening diabetic retinopathy and related eye diseases. Objective To evaluate the …

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double …

A Lotery, S Sivaprasad, A O'Connell, RA Harris… - The Lancet, 2020 - thelancet.com
Background In chronic central serous chorioretinopathy (CSCR), fluid accumulates in the
subretinal space. CSCR is a common visually disabling condition that develops in individuals …

Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration

…, S Heldner, T Bogumil, T Heah, S Sivaprasad - British Journal of …, 2015 - bjo.bmj.com
Background/aims Real-life anti-vascular endothelial growth factor (VEGF) therapy use in
patients with wet age-related macular degeneration (wAMD) was assessed in a retrospective, …

Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective

S Sivaprasad, B Gupta, R Crosby-Nwaobi… - Survey of ophthalmology, 2012 - Elsevier
The alarming rise in diabetes prevalence is a global public health and economic problem.
Diabetic retinopathy is the most common complication of diabetes and the leading cause of …

Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 …

S Sivaprasad, AT Prevost, JC Vasconcelos, A Riddell… - The Lancet, 2017 - thelancet.com
Background Proliferative diabetic retinopathy is the most common cause of severe sight
impairment in people with diabetes. Proliferative diabetic retinopathy has been managed by …

Circulating microRNAs as novel biomarkers for platelet activation

…, I Drozdov, SR Langley, S Sivaprasad… - Circulation …, 2013 - Am Heart Assoc
Rationale: MicroRNA (miRNA) biomarkers are attracting considerable interest. Effects of
medication, however, have not been investigated thus far. Objective: To analyze changes in …

[HTML][HTML] Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders

…, F Behar-Cohen, ME Hartnett, S Sivaprasad… - Progress in retinal and …, 2022 - Elsevier
In central serous chorioretinopathy (CSC), the macula is detached because of fluid leakage
at the level of the retinal pigment epithelium. The fluid appears to originate from choroidal …

[HTML][HTML] Central serous chorioretinopathy: towards an evidence-based treatment guideline

…, JEE Keunen, RO Schlingemann, S Sivaprasad… - Progress in retinal and …, 2019 - Elsevier
Central serous chorioretinopathy (CSC) is a common cause of central vision loss, primarily
affecting men 20–60 years of age. To date, no consensus has been reached regarding the …

[HTML][HTML] Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK)

S Sivaprasad, B Gupta, MC Gulliford, H Dodhia… - PloS one, 2012 - journals.plos.org
Aims To compare the prevalence of diabetic retinopathy (DR) in people of various ethnic
groups with diabetes in the United Kingdom (UK). Methods The Diabetic Retinopathy In Various …

Micropulsed diode laser therapy: evolution and clinical applications

S Sivaprasad, M Elagouz, D McHugh, O Shona… - Survey of …, 2010 - Elsevier
Many clinical trials have demonstrated the clinical efficacy of laser photocoagulation in the
treatment of retinal vascular diseases, including diabetic retinopathy. There is, however, …